Department of Medicine, McMaster University Medical
Centre, Hamilton, Ontario, Canada L8N 3Z5
The purpose of the study was to examine the roles of
active pyruvate dehydrogenase
(PDHa), glycogen phosphorylase
(Phos), and their regulators in lactate
(Lac
) metabolism during
incremental exercise after ingestion of 0.3 g/kg of either
NaHCO3 [metabolic alkalosis
(ALK)] or CaCO3
[control (CON)]. Subjects
(n = 8) were studied at rest, rest
postingestion, and during constant rate cycling at three stages (15 min
each): 30, 60, 75% of maximal O2
uptake
(
O2 max).
Radial artery and femoral venous blood samples, leg blood flow, and
biopsies of the vastus lateralis were obtained during each power
output. ALK resulted in significantly
(P < 0.05) higher intramuscular
Lac
concentration
([Lac
]; ALK
72.8 vs. CON 65.2 mmol/kg dry wt), arterial whole blood [Lac
] (ALK 8.7 vs. CON 7.0 mmol/l), and leg
Lac
efflux (ALK 10.0 vs.
CON 4.2 mmol/min) at 75%
O2 max. The increased intramuscular
[Lac
] resulted
from increased pyruvate production due to stimulation of glycogenolysis
at the level of Phos a and
phosphofructokinase due to allosteric regulation mediated by increased
free ADP (ADPf), free AMP
(AMPf), and free Pi concentrations.
PDHa increased with ALK at 60%
O2 max but was
similar to CON at 75%
O2 max. The increased
PDHa may have resulted from
alterations in the acetyl-CoA, ADPf, pyruvate, NADH, and
H+ concentrations leading to a
lower relative activity of PDH kinase, whereas the similar values at
75%
O2 max may have
reflected maximal activation. The results demonstrate that imposed
metabolic alkalosis in skeletal muscle results in acceleration of
glycogenolysis at the level of Phos relative to maximal PDH
activation, resulting in a mismatch between the rates of pyruvate
production and oxidation resulting in an increase in
Lac
production.
 |
INTRODUCTION |
INDUCED METABOLIC ALKALOSIS by sodium bicarbonate
(NaHCO3) ingestion in humans has previously been shown to
increase blood Lac
concentration
([Lac
]) during
exercise (10, 33, 37, 46, 63). Unfortunately, the majority of studies
exploring the effects of metabolic alkalosis on
Lac
metabolism have
focussed on the possible performance-enhancing capabilities of
"bicarbonate loading" (31). Ingestion of NaHCO3 is
thought to enhance performance by buffering the lactic acid produced
with exercise, thereby limiting the effects of the decreased intramuscular pH (pHi; see Ref.
31). Metabolic alkalosis through ingestion or infusion of
NaHCO3 has been shown to enhance
performance for short-duration, high-intensity exercise, but the
mechanisms have not been elucidated. Different mechanisms have been
postulated to explain this, including an increase in muscle
Lac
production (10, 63)
and/or enhanced Lac
efflux
from the muscle (44). Lactate accumulation results from the conversion
of nonoxidized pyruvate to
Lac
by lactate
dehydrogenase (LDH) and as such will be influenced by both
pyruvate production from glycogen via glycogen phosphorylase (Phos) and
pyruvate oxidation by pyruvate dehydrogenase (PDH; see Refs. 18, 38).
In an effort to discern the possible mechanisms responsible for the
increased blood
[Lac
] with
metabolic alkalosis, we chose an oral dose of
NaHCO3, previously shown to induce
a significant metabolic alkalosis, to influence plasma
[Lac
], and to
enhance performance (37). Continuous, dynamic constant-rate exercise at
low, moderate, and high intensity was chosen to follow the metabolic
effects, compare fuel utilization with previously described
carbohydrate (CHO) and free fatty acid (FFA) contributions at these
power outputs (50), and to maintain the ATP turnover rate
constant between conditions. This is the first human in vivo study to
examine the key regulatory enzymes, their controllers, and fuel
utilization during continuous dynamic constant rate exercise under
alkalotic conditions.
The aim of the present study was not to examine the performance effect
of an induced metabolic alkalosis during exercise. Rather, the first
aim was to determine the effect of metabolic alkalosis on the key
regulatory enzymes Phos and PDH and their allosteric regulators. The
second aim was to measure the effect of metabolic alkalosis on
glycolytic intermediates, muscle pyruvate production, and pyruvate
oxidation. The third aim was to measure muscle lactate accumulation,
production, and efflux. The last aim was to determine if alkalosis has
any effects on glucose uptake and FFA utilization during exercise.
 |
METHODS |
Subjects
Eight healthy male volunteers participated in the study [age 23 ± 1.8 (SE) yr; height 173 ± 3.8 cm; weight 75.3 ± 4.4 kg]. Written consent was obtained from each subject after
explanation of the purposes and associated risks of the study protocol.
The study was approved by the Ethics Committees of both McMaster
University and McMaster University Medical Center.
Preexperimental Protocol
All subjects completed an initial incremental maximal exercise
test on a cycle ergometer to determine
O2 max and
maximal work capacity using a metabolic measurement system
(Quinton Q-Plex 2; Quinton Instruments, Seattle, WA). Mean
O2 max for the group was 3.2 ± 0.2 l/min. None of the subjects was well trained, but all
participated in some form of regular activity. Each subject was
instructed to refrain from caffeine, alcohol, and exercise for 24 h
before each trial, and studies were carried out at the same time of day.
Experimental Protocol
Each subject participated in two experimental trials
separated by 2-3 wk and was randomized to receive capsules
containing either 0.3 g/kg of
NaHCO3 [metabolic alkalosis
(ALK)] or 0.3 g/kg of CaCO3
[control (CON)]. On the morning of each trial, the subjects reported to the laboratory after consumption of a standard light meal
consisting primarily of CHO. The exercise portion of the protocol
consisted of three levels of continuous, constant-rate exercise on a
cycle ergometer at 30, 60, and 75% of
O2 max, each
maintained for 15 min, which began after insertion of arterial and
femoral venous catheters and ingestion of the required capsules (Fig.
1).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Experimental study protocol. Total of two trials were completed per
subject; 0.3 g/kg of either CaCO3
[control (CON)] or
NaHCO3 [alkalosis
(ALK)] was ingested over the time indicated, each constituting
one trial. Leg blood flow and arterial and femoral venous blood samples
were taken at the times indicated. Exercise bouts refer to three
continuous power outputs of 15 min each. 30, 60, and 75% indicate
cycling intensity of 30%, 60% and 75% maximal
O2 uptake
( O2 max), respectively.
Muscle biopsies were taken at the times indicated. Respiratory
measurements were taken immediately after blood sample/blood flow.
|
|
A radial artery was catheterized with a Teflon catheter (20 gauge, 3.2 cm; Baxter, Irvine, CA) percutaneously after anesthetizing the area
with 0.5 ml of 2% lidocaine without epinephrine (6). A femoral vein
was catheterized percutaneously for insertion of the thermodilution
catheter (model 93-135-6F; Baxter) using the Seldinger
technique (6) after administration of 3-4 ml of lidocaine without
epinephrine. Both the arterial and femoral venous catheters were
maintained patent with sterile, nonheparinized, isotonic saline
solution. Arterial and femoral venous blood samples were simultaneously
taken at rest, rest postingestion, and during each of the three
exercise bouts at 6 and 11 min. Single leg blood flow measurements were
made after blood sampling at the same time points. Single leg blood
flow was determined using the thermodilution technique, as described by
Andersen and Saltin (1). Nonheparinized isotonic saline (10 ml) was
injected, and leg blood flow was calculated by a portable CO monitor
(Spacelab, Redmond, VA). At least three measurements were recorded at
each time point and then averaged.
A total of five percutaneous needle biopsies of the vastus lateralis
were taken (1 at rest, 1 at rest postingestion, and 3 during exercise
at the end of each power output). The resting biopsies were obtained
with the subject lying on a bed. The resting and exercise biopsies were
obtained on opposite legs and then were reversed for the second trial.
Biopsy sites were prepared by making an incision through the deep
fascia under local anesthetic (2% lidocaine without epinephrine), as
described by Bergström et al. (5). Respiratory measurements of
ventilation (
E), O2 uptake
(
O2),
CO2 production
(
CO2), and respiratory
exchange ratio (RER) were measured at 5 and 11 min of each exercise stage.
Muscle Analysis
Muscle samples were immediately frozen in liquid
N2. A small piece (10-35 mg)
was chipped from each biopsy (under liquid
N2) for determination of the
fraction of PDH in the active form
(PDHa), as previously described
(20, 51). The remainder of the sample was freeze-dried, dissected free
of blood and connective tissue, and powdered. One aliquot was analyzed
for Phos activity according to the methods of Young et al. (72).
Briefly, a 3- to 4-mg sample of muscle was homogenized at
20°C for 0.2 ml in 100 mM of Tris/HCl (pH 7.5) containing
glycerol, potassium fluoride, and EDTA. Homogenates were then diluted
with 0.8 ml of the same buffer without glycerol and homogenized further
at 0°C. Total (a + b) Phos activity (measured in the
presence of 3 mM AMP) and Phos in the active
a form (Phos a; measured in the absence of added
AMP) were measured at 30°C with a spectrophotometer. Maximum
velocity (Vmax)
was derived from the equation described by Lineweaver and Burke (41)
where
V is the initial reaction rate
expressed as millimoles dry wt per kilogram per min, S is the
Pi concentration
([Pi]) in millimoles
per liter, and Km
is the Michaelis constant (26.2 mmol/l). The mole fraction of Phos
a is presented as a percentage and is
calculated as
Vmax
a/Vmax(a + b) × 100. Phos a measurements were
made only on exercise samples for two reasons. First, resting samples
must be kept at room temperature for ~30 s before freezing for
accuracy, which would have required two additional biopsies (53).
Ethically, this was not acceptable for the provision of one
measurement. Second, the changes at rest and rest postingestion were
not a main focus of this study. A second aliquot was used to determine
muscle glycogen, fluorometrically, using the enzymatic end-point method
described by Bergmeyer (4). A third aliquot of dry muscle was extracted
in 0.5 M perchloric acid (PCA) and 1 mM EDTA, neutralized to
pH 7.0 with 2.2 M KHCO3, and
analyzed for acetyl-CoA, free CoASH, total CoA, acetylcarnitine, free
carnitine, and total carnitine according to the methods of Cederblad et
al. (11). A fourth aliquot was used to determine ATP, pyruvate, Lac
, phosphocreatine (PCr),
creatine, glucose, glucose 6-phosphate (G-6-P), glucose 1-phosphate
(G-1-P), fructose 6-phosphate
(F-6-P), and glycerol 3-phosphate
(Gly-3-P)
concentrations using the methods described by Bergmeyer (4) and were
adapted for fluorometry. All muscle metabolites were normalized to the
highest total creatine content for a given individual (mean total
creatine = 121.7 ± 6.2 mmol/kg dry wt) to correct for nonmuscle
contamination. Free contents of ADP
(ADPf) and AMP
(AMPf) were calculated as
described by Dudley et al. (23), using the reactants and equilibrium
constants of the near-equilibrium reactions catalyzed by creatine
kinase (CK) and adenylate kinase.
ADPf was estimated using the
measured ATP, PCr, and creatine contents and an estimated
H+ concentration
{[H+],
calculated indirectly from muscle
[Lac
] and
pyruvate concentration ([pyruvate]) using the regression equation of Sahlin et al. (55)}. From this information, the concentration of AMPf was
determined assuming a
Keq of 1.05 for the
adenylate kinase reaction. Free Pi
content was calculated from the sum of the estimated resting free
[Pi] of 10.8 mmol/kg dry wt (23) and the
PCr
G-6-P
F-6-P
Gly-3-P between rest and each time
point during exercise. For the purposes of ADPf,
AMPf, and free
Pi calculations, no differences
were observed between the rest and rest postingestion values;
therefore, the mean of the two values was taken as the resting value.
Blood Sampling and Analysis
Arterial and femoral venous blood samples (~10 ml) were collected in
heparinized plastic syringes and placed on ice. One portion (1-2
ml) of each blood sample was analyzed for blood gas determination (AVL
995 Automatic Blood Gas Analyzer),
O2 and
CO2 content (Cameron Instrument,
Port Arkansas, TX), and hemoglobin (OSM3 Hemoximeter; Radiometer,
Copenhagen, Denmark). A second portion of each sample was deproteinized
with 6% PCA and stored at
20°C until analysis for glucose,
Lac
, and glycerol according
to the methods of Bergmeyer (4) adapted for fluorometry. The third
portion of blood was immediately centrifuged at 15,900 g for 2 min, and the plasma
supernatant was frozen and later analyzed for FFA (Wako, NEFA C test
kit; Wako Chemical, Montreal, Canada). Hematocrit was determined on
blood samples using a heparinized microcapillary tube centrifuged for 5 min at 15,000 g.
Leg Uptake and Release of Metabolites,
O2, and
CO2
Uptake and release of metabolites (glucose, glycerol,
Lac
) were calculated from
their whole blood measurements in arterial and femoral venous blood and
leg blood flow according to the Fick equation. Because there were
differences in the hematocrit over time within a condition and between
matched arterial and femoral venous samples, venous samples were
corrected for fluid shifts. Fluid shifts for the whole blood
measurements were corrected using the differences in hemoglobin (Hb) to
calculate a percent change in blood volume (%
BV), as calculated by
the equation (assuming no change in intravascular hemoglobin; see Ref.
30)
This
value was then multiplied by the measured venous value to yield a
corrected value that was used in determining uptake/release for that
metabolite. Uptake and release of plasma FFA were determined as above,
but venous values were corrected using changes in plasma protein
concentration to correct for changes in plasma water (30). The leg
O2 and
CO2 were calculated from
their respective arterial and femoral venous content differences and
blood flow.
Subjects exercised at a constant rate, and because no significant
differences occurred in blood flows or metabolite concentrations between the 6- and the 11-min sampling points at each power output, the
two values were averaged to obtain one value for each power output.
Reported values are for the single leg only.
Calculations
Flux through Phos and therefore glycogenolysis was calculated from the
differences in glycogen utilization divided by time. PDHa flux was estimated from the
PDHa as measured in wet tissue and
converted to dry tissue using the wet-to-dry ratio. Pyruvate production
was calculated from the sum of the rates of glycogen breakdown and
glucose uptake minus the sum of the rates of accumulation of muscle
glucose, G-6-P, and
F-6-P.
Lac
production was
calculated from the sum of the rates of muscle Lac
accumulation and
Lac
release. Pyruvate
oxidation was calculated as pyruvate production minus
Lac
production. All values
are reported in millimoles per kilogram per minute dry weight and are
for a single leg only. All values were calculated in three carbon units
and assume a wet muscle mass of 5 kg.
Intramuscular pH.
Intramuscular pH (pHi) was calculated from the
[Lac
] and
[pyruvate] according to the methods of Sahlin et al. (55).
Lac
gradient and
[H+]
gradient.
The Lac
gradient between
the plasma and muscle for both trials was calculated for arterial and
femoral venous blood at 75%
O2 max only. The
Lac
gradient between the
muscle and arterial plasma was calculated as the difference between the
wet weight intramuscular
[Lac
] and
arterial plasma
[Lac
]. The
Lac
gradient from
muscle-to-femoral venous plasma was calculated as above using the
noncorrected venous values. The arterial-to-muscle and femoral
venous-to-muscle [H+]
gradients were calculated as the difference between the respective blood compartment [H+]
and the calculated intramuscular
[H+].
Statistical Analysis
Data were analyzed using two-way ANOVA with repeated measures
(treatment × time), except where otherwise stated. When a
significant F ratio was found, the
Newman-Keuls post hoc test was used to compare means. The following
data were analyzed using a two-tailed paired dependent-sample
Student's t-test: Phos
a and glycogen utilization at each
power output. Data are presented as means ± SE. Differences were
considered significant at P < 0.05.
 |
RESULTS |
Muscle Metabolism
Phos.
Phos a activity did not change with
power output during CON. However, with ALK, Phos
a progressively decreased with power output and was significantly lower at 75%
O2 max with ALK
compared with CON (ALK 37.9 ± 5.1 vs. 48.8 ± 5.0 mmol dry
wt · kg
1 · min
1; Fig.
2).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Phosphorylase (Phos) a, mole fraction
% during cycling at the various power outputs.
+ Significantly different from CON at matched time
points. There was a significant main effect of time with each
condition. Values are means ± SE.
|
|
Glycogen. Resting and rest
postingestion muscle glycogen concentrations were not different between
conditions (Table 1). Muscle glycogen
content decreased with increasing power output, but to a greater degree
with ALK (Table 1). During the complete exercise study, total muscle
glycogen utilization was 25% greater with ALK compared with CON (305 ± 9 vs. 229 ± 10 mmol/kg dry wt). No differences in
muscle glycogen utilization were observed at 30%
O2 max, but muscle
glycogen utilization was significantly higher at both 60 and
75%
O2 max with ALK
compared with CON (60%
132 ± 15 vs. 75 ± 6 mmol/kg dry wt; 75%
133 ± 15 vs. 113 ± 12 mmol/kg dry wt; Fig. 3).
View this table:
[in this window]
[in a new window]
|
Table 1.
Muscle glycogen and glycolytic intermediate contents in vastus
lateralis at rest, rest postingestion, and during cycle ergometry at
30, 60, and 75% O2 max
after either CON or ALK
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Glycogen utilization for each power output. Data are means ± SE.
+ Significantly different from CON at matched time
points.
|
|
Glucose, G-6-P, F-6-P, G-1-P, and
Gly-3-P. Intramuscular accumulation of glucose
increased with exercise similarly between conditions (Table 1).
Intramuscular G-6-P concentration
([G-6-P]) and
F-6-P concentration
([F-6-P]) increased with
increasing power output for the first and second power outputs, but
each was significantly lower with ALK during 75%
O2 max only (Table 1).
Muscle G-1-P and
Gly-3-P were similar between
conditions, increasing with each power output (Table 1).
Lactate and pyruvate.
Intramuscular
[Lac
] increased
with each power output but was significantly higher with ALK at both
60% (ALK 40.9 ± 8.3 vs. CON 26.2 ± 5.0 mmol/kg dry wt) and
75% (ALK 72.8 ± 11.8 vs. CON 65.2 ± 10.1 mmol/kg dry wt)
O2 max (Fig.
4). Muscle [pyruvate] increased
with each power output and was similar between conditions at 30 and
75%
O2 max
and significantly higher with ALK during the second power output (Fig.
4).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Muscle lactate (Lac ) and
pyruvate concentrations with ALK and CON at rest and during each power
output. + Significantly different from CON at matched
time points. Values are means ± SE. dw, Dry weight. There was a
significant main effect of time for both
Lac and pyruvate,
specifically at 60 and 75%
O2 max.
|
|
PDHa.
Resting (ALK 0.55 ± 0.01 vs. CON 0.55 ± 0.08 mmol wet wt
· kg
1 · min
1)
and rest postingestion (ALK 0.55 ± 0.11 vs. CON
0.53 ± 0.05 mmol wet wt · kg
1 · min
1)
PDHa were not different between
conditions. Under both conditions, PDHa increased progressively with
each power output but was significantly higher at 60%
O2 max (4.17 ± 0.23 vs. 3.77 ± 0.27) with ALK compared with CON,
respectively (Fig. 5).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Muscle active pyruvate dehydrogenase
(PDHa) activity with ALK and CON
at rest and during each power output. + Significantly
different from CON at matched time points. Data are means ± SE. ww,
Wet weight. There was a significant main effect of time for each
condition.
|
|
CoA, carnitine, and acetylated forms.
Total muscle CoA was not different between conditions at rest or during
exercise (Table 2). The acetyl-CoA
concentration ([acetyl-CoA]) increased with each power
output similarly between conditions at 30%, but during both 60 and
75%
O2 max the
[acetyl-CoA] was significantly lower with ALK (Table 2).
Free CoASH declined equally between conditions with exercise (Table 2).
The acetyl-CoA-to-CoASH ratio was also significantly lower at 75%
O2 max with ALK (0.26 ± 0.02 vs. 0.37 ± 0.06; Table 2). Acetylcarnitine followed a
similar pattern to acetyl-CoA (increasing with each power output) but
was not different between conditions (Table 2). Muscle total carnitine content increased significantly from rest to 75%
O2 max to the same
degree in each condition, whereas free carnitine decreased in a
reciprocal manner with increasing power output. There were no
differences in total carnitine between conditions, but free carnitine
was significantly lower at 60%
O2 max during ALK
compared with CON (Table 2).
View this table:
[in this window]
[in a new window]
|
Table 2.
Muscle acetyl group content in vastus lateralis at rest, rest
postingestion, and during cycle ergometry at 30, 60, and 75%
O2 max after either CON or
ALK
|
|
ATP, ADPf,
AMPf, free Pi,
and PCr.
Muscle ATP concentration ([ATP]) was unaltered by exercise
or as a result of ALK. Muscle
[ADPf] and
[AMPf] increased with each power output, but both were significantly higher with ALK at 60 and 75%
O2 max (Table
3). Free
Pi increased with each power
output, but to a significantly greater degree with ALK (Fig. 6). The [PCr] decreased with increasing
power output but was significantly more depleted at each power output
during ALK compared with CON (Fig. 6).
View this table:
[in this window]
[in a new window]
|
Table 3.
Muscle high energy phosphate content in vastus lateralis at rest, rest
postingestion, and during cycle ergometry at 30, 60, and 75%
O2 max after either CON or
ALK
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Phosphocreatine (PCr) and free Pi
with ALK and CON at rest and at each power output. There was a
significant main effect of time for each condition.
+ Significantly different from CON at matched time
points. Values are means ± SE.
|
|
Pyruvate production and oxidation and lactate production and
oxidation.
Pyruvate production increased with exercise but was significantly
higher during both the second and third power outputs with ALK.
Pyruvate oxidation increased with exercise similarly between conditions
at both 30 and 75%
O2 max. At 60%
O2 max,
pyruvate oxidation was significantly higher during ALK (Table
4). Relative pyruvate oxidation expressed
as the percentage of pyruvate produced that was oxidized was similar
between conditions for both 30 and 75%
O2 max. However,
relative pyruvate oxidation was significantly higher during 60%
O2 max with ALK (Table
4). Lactate production was similar between conditions during the first
two power outputs but was significantly higher at 75%
O2 max during ALK
(Table 4).
View this table:
[in this window]
[in a new window]
|
Table 4.
Muscle pyruvate production, oxidation, and lactate production at 30, 60, and 75% O2 max after
either CON or ALK
|
|
Blood Metabolites, Blood Flow, and Exchange Across the Leg
Blood pH,
PCO2, and
HCO
3. Arterial
pH and HCO
3 (Fig.
7) and venous pH and
HCO
3 (Table
5) were all significantly higher during ALK
compared with CON at rest postingestion and each of the three power
outputs.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Arterial blood pH, PCO2, and
HCO 3 during ALK and CON at rest and
during each power output. + Significantly different
from CON at matched time points. Values are means ± SE.
|
|
View this table:
[in this window]
[in a new window]
|
Table 5.
Arterial concentration of bloodborne substrates during rest, rest
postingestion, and during cycle ergometry at 30, 60, and 75%
O2 max after either CON or
ALK
|
|
Leg blood flow and leg respiratory
quotient. Leg blood flow increased progressively with
exercise similarly between conditions (Table
6). Leg
O2,
CO2, and leg respiratory
quotient were not different between conditions, increasing with each
power output (Table 6).
View this table:
[in this window]
[in a new window]
|
Table 6.
Leg blood flow, RQ, CO2 production, and O2
uptake at rest, rest postingestion, and during cycle ergometry at 30, 60, and 75% O2 max after
either CON or ALK
|
|
Blood lactate and flux.
Arterial [Lac
]
increased progressively with each power output but was significantly
higher at both 60 and 75%
O2 max with ALK (Table
5). Net Lac
release across
the leg increased with each power output but was significantly higher
during 75%
O2 max with
ALK (Fig. 8).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
Glucose uptake and lactate release across the leg during ALK and CON at
rest and for each power output. + Significantly
different from CON at matched time points. There was a significant main
effect of time for glucose uptake and
Lac release. Values are
means ± SE.
|
|
Blood FFA and glycerol. Arterial
plasma [FFA] declined progressively with exercise similarly between
conditions (Table 5). FFA release across the leg occurred at rest
postingestion and at each of the power outputs during CON. However,
with ALK, a significantly lower net release occurred at rest
postingestion, whereas during exercise at each of the three power
outputs, a net uptake occurred (Fig. 9).
Arterial [glycerol] increased with each power output similarly
between conditions (Table 5). Glycerol release across the leg occurred
at rest postingestion and 30%
O2 max similarly
between conditions. During 60%
O2 max, a net release
occurred with CON, whereas a net uptake occurred with ALK. At 75%
O2 max, a net uptake
across the leg occurred for both conditions but was significantly lower
with ALK (Fig. 9).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 9.
Glycerol flux and free fatty acid (FFA) flux across the leg during ALK
and under CON conditions at rest and during each power output.
+ Significantly different from CON at matched time
point. There was a significant main effect of time with each condition.
Values are means ± SE.
|
|
Blood glucose and flux. Arterial
[glucose] (Table 5) and leg glucose uptake (Fig. 8) were similar at
all power outputs between conditions.
Lactate Gradient,
H+ Gradient, and
pHi
The lactate gradient between both the arterial and femoral venous
plasma and muscle was not different between conditions at 75%
O2 max (Table
7). The
[H+] gradient between
the arterial blood and muscle and the femoral venous blood and muscle
were both significantly elevated with ALK compared with CON during 75%
O2 max (Table 7).
Intramuscular [H+] was
significantly elevated during both the second and third power outputs
with ALK (Table 7).
View this table:
[in this window]
[in a new window]
|
Table 7.
Lactate and hydrogen ion gradients from arterial to muscle and femoral
venous to muscle during cycle ergometry at 75%
O2 max only
after either CON or ALK
|
|
Respiratory Gas Exchange Variables
Whole body
O2 increased
similarly between conditions with each power output (Table
8). Whole body
CO2 was
significantly higher during 60% (2.39 ± 0.09 vs. 2.28 ± 0.13)
and 75% (3.18 ± 0.11 vs. 3.01 ± 0.22)
O2 max in ALK
compared with CON, respectively. RER was also significantly higher
during ALK at both 60 and 75%
O2 max (Table 8).
E increased similarly between conditions (Table 8).
 |
DISCUSSION |
The present study examined the effects of induced alkalosis on the
metabolic responses of skeletal muscle during continuous, dynamic, constant-rate exercise at three power outputs (30, 60, and
75%
O2 max). The main
effects of alkalosis during this type of exercise occurred during the
two higher power outputs and included an enhanced glycogen utilization
with a concomitant increase in pyruvate production, increased
intramuscular Lac
accumulation, enhanced Lac
efflux from the exercising leg, and a greater relative activation of
Phos than PDHa.
Lactate production within the muscle is dependent on the balance
between the rates of pyruvate production and oxidation. Intramuscular Lac
is formed from pyruvate
by the action of the near-equilibrium enzyme LDH (47). Although greater
pyruvate production was observed at the two highest power outputs,
Lac
production was elevated
over CON values only during 75%
O2 max (Table
4). Lactate production at the highest power output resulted from a
significant degree of mismatch between the rates of
glycogenolysis/glycolysis and maximal
PDHa activation. At 60%
O2 max, the absence of
an increase in lactate production despite an increased pyruvate
production resulted from an enhanced pyruvate oxidation relative to
production due to greater PDHa
with ALK. These changes resulted from the effect of alkalosis on the
rate-limiting enzymes Phos, phosphofructokinase (PFK), and PDH. The
main control points for glycogenolysis/glycolysis involve Phos and PFK,
respectively, whereas entry into the oxidative pathway is controlled by
PDHa (47).
Phos
Phos is the flux-generating enzyme responsible for glycogenolysis
within skeletal muscle and is subject to both covalent and allosteric
regulation. Phos a, considered the
active form, is active in the absence of
AMPf, whereas Phos
b, the less active form, requires
AMPf (12). Covalent
b-to-a
transformation is mediated by Phos kinase
a, which is activated by either an
increase in epinephrine or cytosolic
Ca2+ concentration
([Ca2+]) via
cAMP-dependent and -independent mechanisms, respectively (54).
Posttransformational allosteric activation of Phos
b is mediated by AMP and IMP, whereas
inhibition is mediated by ATP and
G-6-P. Substrate regulation of both
forms of Phos by the free Pi and
glycogen concentrations is equally important (12, 18).
Phos a was significantly reduced at
the highest power output with ALK. This reduction presumably reflects
the inhibition of Phos kinase a by the
increased [H+] (Table
3). Previous studies have demonstrated this relationship between
[H+] and Phos
a in intensely exercising muscle (13).
However, the mole fraction of Phos in the
a form is not the sole determinant of
glycogenolytic flux, as previous studies examining the relationship between Phos a transformation and
glycogenolysis have demonstrated (14, 18, 34, 54). The present results
of a higher glycogen utilization at 75%
O2 max
(133 ± 6 vs. 113 ± 12; Fig. 3) despite a lower Phos
a (Fig. 2) and the observed greater
glycogen utilization (132 ± 15 vs. 75 ± 6; Fig. 3) despite
similar Phos a (Fig. 2) at 60%
O2 max with ALK are in
agreement with these previous studies. Additionally, there may have
been a hormonal effect throughout exercise due to a decrease in the
circulating epinephrine concentration ([epinephrine]) with
ALK, which may have contributed to the lower observed Phos
a. Bouissou and colleagues (10)
observed a 34% reduction in the plasma [epinephrine]
and higher intramuscular [Lac
] with
alkalosis in humans who cycled to exhaustion. The enhanced glycogenolysis despite similar or lower Phos
a transformation with ALK likely
resulted from posttransformational modulation by increases in the
AMPf, and IMP concentrations and
an increase in its substrate free Pi.
AMP and IMP have been shown to stimulate Phos
a (2, 54) and Phos
b (2, 15). AMP acts on Phos
a by reducing the
Km for
Pi from 26.8 to 11.8 mM in the
presence of as little as 0.01 mM AMP (2, 54). AMP acts in a similar
manner on Phos b but with a higher
Km. Both the
[AMPf] and free
[Pi] were
significantly greater with ALK during the second and third power
outputs and were well above the required concentrations for activation
(Table 3 and Fig. 6). In support of the close relationship between Phos activity, glycogenolytic flux, and the
[AMPf], other studies
using caffeine ingestion (17), increased FFA availability (24, 48), and
short-term training (16) have demonstrated glycogen sparing during
exercise associated with blunted
AMPf accumulation. The increased
[AMPf] may have
augmented activation of both Phos a and Phos b. IMP activates Phos
b with a
Km of 1.2 mM (2).
IMP concentration ([IMP]) was not measured in the present
study but has been shown previously to increase with exercise and when
the [ADPf] increases
(64). The [ADPf] was
significantly elevated with ALK, which may have led to an increase in
the [IMP], which in turn may have activated Phos
b.
ATP and G-6-P are both inhibitors of
Phos b. ATP has an inhibitory constant
(Ki) of ~2
mM, whereas G-6-P has a
Ki of ~0.3 mM
(25). In the present study, [ATP] remained constant
throughout exercise and between conditions at levels above the
Ki.
[G-6-P] was significantly
lower with ALK at 75%
O2 max but remained above the Ki.
These combined results should favor a reduction in Phos activity and
glycogenolysis. However, it has been previously demonstrated that the
inhibition of Phos b by both ATP and
G-6-P can be overcome when the
[AMPf] increases
sufficiently (18). In addition, previous studies have demonstrated that
glycogenolytic flux is closely tied to the availability of its
substrate, free Pi, and the
allosteric regulator, AMPf, both
of which were elevated with ALK (16, 17).
In summary, Phos activity and therefore glycogenolytic flux results
from the combination of covalent, allosteric, and substrate regulation.
During ALK, despite a lower transformation of Phos a, glycogenolytic flux was enhanced,
and glycogen utilization increased during the second and third power
outputs due to the maintenance of flux through posttransformational
allosteric activation of Phos a + b by an increased
[AMPf], and possibly
[IMP], and an increase in the concentration of its substrate, free
Pi.
PFK
PFK plays a key role in the regulation of glycolysis and therefore
pyruvate production. PFK catalyzes the conversion of
F-6-P to fructose 1,6-bisphosphate
with the use of ATP (47), with the relative enzyme activity reflected
by changes in the [F-6-P] and [G-6-P], with which it
is in equilibrium. PFK is subject to regulation by a large number of
metabolites that function to either inhibit or activate the enzyme
complex. ATP and H+ inhibit,
whereas ADP, AMP, Pi, and
F-6-P activate, the enzyme complex,
with the net enzyme activity resulting from the combination of these
inputs (66). These are the most potent regulators, which reflect energy
state and fuel utilization within the cell and thereby provide feedback
regulation to adjust glycolytic flux.
[ATP] remained constant between trials and across power
outputs, which provided a small degree of inhibition. Also, during the
highest power output, intramuscular
[H+] was significantly
elevated for both trials (Table 3), which would provide inhibition, as
previous in vitro studies using constant [ATP] with
declining pH have demonstrated (22, 65). Human exhaustive exercise
protocols have found similar changes reflecting reductions in PFK
activity with reduced intramuscular
[H+] (36, 59). The
magnitude of the pH inhibition can be modulated by increases in
[F-6-P] and the activators
ADP, AMP, and free Pi. Alkalosis led to increases in
[F-6-P] and
[G-6-P] during the third
power output but to a significantly lower magnitude than CON. At this
power output, pHi was
significantly lower compared with CON but may have failed to inhibit
PFK activity due to positive modulation by the significantly elevated
[AMPf],
[ADPf], and
[Pi]. AMP acts by
augmenting PFK's affinity for its substrate,
F-6-P (9). The increased
[F-6-P], although lower
than CON, was elevated above the
Km of
0.1-0.2 mM, which could have opposed the pH inhibition by
decreasing the affinity of the ATP binding site (39). The accompanying
rise in the [G-6-P],
although above the
Ki for Phos, may
have been overridden by the positive modulation of Phos by the
increased [AMPf] and
[Pi]. Previous in
vitro studies have also demonstrated substantial acceleration of
glycolysis with the lowering of the ATP-to-ADP ratio, a situation
present with ALK at both 60% (CON 132 vs. ALK 87) and 75%
O2 max (CON
80 vs. ALK 55) due to the increase in
[ADPf] (71). The
stimulatory effect of an increase in
[ADPf] on PFK activity
has been shown to substantially increase with as little as a 2 mM
increase in Pi, which also
occurred in the present study with ALK (71).
The combined results demonstrate enhanced glycogenolytic/glycolytic
flux with ALK due to allosteric upregulation of both Phos and PFK
activity, leading to the increased glycogen utilization and pyruvate
production at the two highest power outputs.
PDH
PDHc is a mitochondrial enzyme complex that catalyzes the
decarboxylation of glycolytically derived pyruvate and therefore reflects the rate of CHO entry into the tricarboxylic acid (TCA) cycle.
PDHc transformation between the active
(PDHa) and inactive (PDHb) forms is regulated by the
balance between PDH kinase (PDHK; deactivating) and PDH phosphatase
(PDHP; activating; see Refs. 52, 68). The relative phosphatase/kinase
activity is controlled by the mitochondrial acetyl-CoA-to-CoASH,
ATP-to-ATP, and NADH-to-NAD+
ratios and the allosteric regulators
Ca2+, pyruvate, and
H+. Increases in the ratios
decrease PDHa transformation,
whereas decreases in the ratios have the opposite effect. Increases in [pyruvate] inhibit the kinase only, increases in
[Ca2+] inhibit the
kinase and activate the phosphatase, and increases in
[H+] activate the
phosphatase only (51, 52, 68). Due to the complex interaction of
regulators and the observed differences in
PDHa between conditions, the
changes occurring at 60 and 75%
O2 max will be
discussed separately.
Changes in PDHa at 60%
O2 max.
In the present study, PDHa
increased with each power output as a result of contraction-induced
increases in the
[Ca2+] (19, 21, 34).
However, increases in the
[Ca2+] cannot be the
sole mechanism responsible for the increased
PDHa with ALK, since the power
outputs were identical between trials. The elevated
PDHa with ALK resulted from
changes in the allosteric regulators acetyl-CoA, ADPf,
H+, pyruvate, and the NADH-to-NAD+ ratio.
The [acetyl-CoA] was significantly lower during this power
output with ALK (Table 2) and probably reflects reduced FFA utilization in the face of increased glycogen utilization and pyruvate production (Table 4). Because acetyl-CoA inhibits PDHP, the reduced concentration would serve to activate the phosphatase and therefore contribute to the
greater PDHa observed with ALK
(68).
The ATP-to-ADP ratio was significantly reduced with ALK (87 vs. 132) at
this power output due to a significant elevation in the
[ADPf] without changes
in [ATP] (Table 3). This ratio effects PDHK only, as ATP is
the substrate for the reaction and therefore competes with its product
ADP, which inhibits catalytic activity (68). The lower ATP-to-ADP ratio
observed with ALK could have resulted in lower PDHK activity and
therefore contributed to the greater
PDHa observed.
Hydrogen ion has been shown to activate
PDHa in acidotic perfused rat
hearts (49) and has been attributed to the differences in pH optimum of
PDHK and PDHP. PDHK has a pH optimum of 7.0 ~ 7.2, with increased
inhibition as pH falls, whereas PDHP has a pH optimum of 6.7 ~ 7.1 (35). In the present study, the calculated intramuscular
[H+] was significantly
elevated at this power output with ALK compared with CON (Table 3),
which may have resulted in greater activation of the phosphatase and
contributed to the increased PDHa observed.
The intramuscular [pyruvate] was also significantly
elevated with ALK at this power output (Fig. 4). Pyruvate is a potent stimulator of PDHa, since it is
both substrate and an inhibitor of PDHK with a
Ki of
0.5-2.0 mM (42). In the present study, the intramuscular
[pyruvate] measured at this power output with ALK is below
the Ki. However,
the [pyruvate] was determined from a biopsy taken at the
end of the exercise bout, and given that both glycogen utilization and
pyruvate production were significantly elevated, it is possible that
the [pyruvate] rose above the
Ki during the
initial stages of exercise (20, 51). In addition, the lactate
production rate remained similar to CON despite the elevation in
pyruvate production, suggesting that most of the pyruvate made
available to PDHa was oxidized and
therefore may not be reflected by the intramuscular
[pyruvate] in the sample taken at the end of exercise. This
is further supported by the observation that the amount of pyruvate
oxidized relative to that produced was significantly elevated with ALK
at this power output (Table 4).
Neither the NADH concentration ([NADH]) nor the
NADH-to-NAD+ ratio was measured in
the present study. However, previous studies using indirect techniques
have shown that the [NADH] decreases and therefore the
NADH-to-NAD+ ratio declines with
high-intensity exercise (29, 60), which would favor an increase in
PDHa. In addition, the markedly
increased glycogen utilization with ALK may have led to reduced FFA
utilization functioning as the "glucose-fatty acid cycle
reversed," as previously demonstrated by Sidossis et al. (56, 57).
These researchers have demonstrated in exercising humans that the
intracellular availability of CHO (rather than FFA) determines the
nature of substrate oxidation when both CHO and FFA are made available
during exercise. The mechanism whereby enhanced CHO availability
reduces FFA oxidation is not precisely known, but findings from in
vitro studies using human tissue (61) and human exercise studies (56) point to the inhibition of long-chain fatty acid entry into the mitochondria by inhibition of carnitine palmitoyltransferase I (CPT-1).
The mechanism responsible for CPT-1 inhibition is not clear but may be
mediated by a pH effect, as it has been shown in isolated rat muscle
preparations that CPT-1 is inhibited by a low pH (62). In humans, the
pH inhibition has recently been shown to be more sensitive than that of
rats, with inhibition at a pHi of
~6.8 (61). The reduced FFA utilization would lead to reduced
intramitochondrial [NADH]. Cytosolic [NADH]
would also decrease, as NAD+ would
be required for the maintenance of glycolytic flux and would be
provided from the conversion of pyruvate to
Lac
. In support of this is
the observation that intramuscular
[Lac
] increased
with ALK in the absence of an increase in
Lac
production (Fig. 4 and
Table 4). Because the mitochondrial and cytosolic compartments are
thought to be in equilibrium, the overall result would be a reduction
in PDHK activity due to decreased [NADH] and an increase in
PDHP due to increased
[NAD+] and therefore
contribute to the elevated PDHa
seen with ALK at this power output. The absence of a
difference in both the leg RQ and mouth RER reflecting a change in the
relative CHO and FFA utilization is not surprising. Previous authors
have demonstrated the lack of sensitivity of both measures in detecting
small changes in fuel utilization during high-intensity exercise (50).
In summary, the significant increase in
PDHa observed with ALK at 60%
O2 max can be
attributed to the combined inhibitory effects of a decrease in the
[acetyl-CoA], an increase in the [ADPf],
[pyruvate], and
[Ca2+] on PDHK, and
the stimulatory effects of the elevated
[H+] on PDHP.
Changes in PDHa at 75%
O2 max.
At this power output, PDHa
transformation was similar between conditions and reflects the
attainment of maximal PDHa (Fig. 5). Previous studies have shown maximal activation at this power output
(34, 50). The increased pyruvate production with ALK resulted from a
slightly higher glycogen utilization. The absence of a difference in
the relative pyruvate oxidation rates between conditions was due to the
similar rates of PDHa. The higher
lactate production rate observed with ALK resulted from the higher
glycogenolytic/glycolytic rate. However, at this power output with ALK,
the major fate of the lactate produced was efflux from the muscle and
not intramuscular accumulation, which will be discussed later.
Cellular energetics.
The rate of mitochondrial ATP production is regulated by
O2 availability and the
[NADH]-to-[NAD+] and
the [ATP]-to-[ADP] × [Pi] ratios (70).
O2 availability was not limiting in the present study in
either trial, as neither the mouth
O2 nor O2
uptake across the leg was different (Tables 6 and
8). However, differences in glycogen and FFA
utilization were apparent. During the two higher power outputs with
ALK, there was a decrease in FFA utilization, as evidenced by
decreased [acetyl-CoA] and the markedly higher glycogen
utilization. During CON, the significantly lower glycogen utilization
necessitated an increase in FFA utilization to match energy production
to ATP demand. The reduced FFA utilization with ALK may have decreased
the mitochondrial [NADH], which would necessitate a higher
[ADPf] and
[Pi] to drive oxidative phosphorylation according to the equation
(70)
|
(1)
|
where c3+ and
c2+ are the oxidized and reduced
forms of mitochondrial cytochrome c,
respectively, and the subscripts i and e refer to the
intramitochondrial and extramitochondrial pools of reactants,
respectively. This phenomenon of an obligatory increase in the
[ADPf] and
[Pi] was observed with
ALK during the higher power outputs (Table 3 and Fig. 6). The CK
reaction and PCr play key roles in the regulation of oxidative
phosphorylation and other metabolic processes as an "energy
buffer" and an "energy transport" system between the sites of
ATP production and ATP utilization (67). The CK/PCr system is very
sensitive to changes in intracellular [ADPf] and serves to
keep this concentration low to prevent the inactivation of cellular
ATPases and the net loss of cellular adenine nucleotides (67). In
addition to functioning as a "barometer" for the intracellular
[ADPf] and therefore
mitochondrial respiration, the CK/PCr system acts as a proton buffer,
since the production of ATP consumes both ADP and
H+, which are both products of ATP
hydrolysis
|
(2)
|
The
coupling of CK with the ATPases at the site of utilization prevents the
local acidification at the initiation of exercise before activation of
glycogenolysis. The hydrolysis of PCr also liberates free
Pi at the onset of exercise, which
is essential for the activation of glycogenolysis and glycolysis (3,
67). The increased degradation of PCr usually reflects a lack of
mitochondrial-derived ATP from oxidative phosphorylation (70). In the
present study, the increased PCr breakdown observed during ALK (Fig. 6)
may have resulted from either a reduced [NADH] that
accompanied a reduction in FFA utilization (Eq. 1) or may have resulted from a change in the
[H+] with ALK
(Eq. 2). Unfortunately, it is not
clear from the present results which mechanism occurred first or what
the exact mechanism is. Regardless of the mechanism, it is clear that
the increased degradation of PCr led to elevation in the free
[Pi], which
contributed to the increased glycogenolysis observed with ALK, and is
in agreement with previous studies examining the effect of increased
FFA availability in rats (26) and humans (24), which have found that
the concentrations of ADP, Pi,
PCr, and NADH have direct effects on TCA cycle activity, mitochondrial
respiration, and glycogen metabolism.
Lactate Metabolism and Transport
Intramuscular lactate accumulation reflects the balance between the
rates of lactate production and efflux from the muscle (7, 38).
Previous studies in humans employing metabolic alkalosis have focused
on the effects of alkalosis on blood
[Lac
] and have
demonstrated similar results to the present study, i.e., an increase in
the blood [Lac
]
(10, 27, 33, 37, 46, 69). Only one study has investigated the effects
of alkalosis on intramuscular lactate accumulation and, as in the
present study, an increase in the muscle
[Lac
] was found
(63). Only one study has examined lactate efflux during alkalosis, and
similar results to the present study, i.e., an increase in lactate
efflux, were found (33). However, none of the studies was able to
elucidate the mechanisms responsible for these observations during
induced metabolic alkalosis.
Lactate production during ALK at 75%
O2 max was increased
compared with CON and resulted from the mismatch between the rates of
glycogenolysis and PDHa flux, as
evidenced by enhanced pyruvate production and significantly higher
glycogen utilization in the absence of a difference in
PDHa between trials (Fig. 3 and
Table 4). The similar PDHa between
trials reflects maximal activation and is supported by the similar
rates of pyruvate oxidation at this power output (Table 4). Therefore,
the only difference between trials at this power output was the
augmented CHO utilization and thus glycogenolytic flux, which greatly
exceeded the maximal PDHa flux.
Previous studies have demonstrated that a mismatch does exist between
the maximal rates of Phos and PDHa
at higher power outputs, resulting in a significant increase in lactate production (34, 51).
Intramuscular lactate accumulation is also a function of the rate of
efflux from the muscle (38). ALK significantly increased arterial whole
blood [Lac
] and
plasma [Lac
]
(Table 5) during both the second and third power outputs and enhanced
efflux from the exercising leg during the highest power output only
(Fig. 8). Blood
[Lac
]
represents the balance of lactate entry from muscle and uptake by
inactive tissue (7). The present results can be explained by both
enhanced lactate transport out of the exercising leg and possibly
reduced uptake by nonexercising tissue.
Lactate transport across the sarcolemma occurs via a monocarboxylate
lactate-proton cotransport protein and as such is the rate-limiting
step in lactate efflux (38, 45). Kinetic studies of the transporter
using isolated sarcolemmal vesicle preparations have shown it to have a
high affinity for L-lactate and to be sensitive to changes
in both the Lac
and
H+ concentration gradients (38).
In the present study with ALK, there was an increase in the
intramuscular
[Lac
], but the
[Lac
] gradient
between the muscle and both the arterial plasma and femoral venous
plasma compartments was similar between conditions (Table 7).
Therefore, the enhanced lactate efflux observed with ALK was not a
function of the increase in the intramuscular
[Lac
]. This
means that some other factor likely had an effect on the transporter
(8). The most plausible effector is
H+, as the
[H+] gradient between
muscle and both the arterial and femoral venous blood was significantly
elevated with ALK (Table 7; see Refs. 38, 40). ALK also induced a
significant elevation in extracellular HCO
3 concentration
([HCO
3]) that may have
contributed to the enhanced lactate efflux from the muscle. The
importance of external
[HCO
3] on lactate efflux
has been demonstrated in isolated muscle preparations with low external
[HCO
3] yielding reduced lactate efflux (32, 43, 58). In addition, studies employing metabolic
alkalosis in exercising humans (10, 27, 33, 37, 46, 63, 69) have
consistently demonstrated increases in the appearance of lactate in the
plasma when accompanied by increases in
[HCO
3]. During ALK in the
present study, extracellular
[HCO
3] was significantly
elevated in both arterial and femoral venous blood at rest
postingestion and remained elevated throughout each of the three power
outputs, which is an agreement with the above evidence (Table 5).
Additionally, decreased lactate uptake by inactive tissue may have
contributed to the higher arterial
[Lac
] with ALK.
Uptake by inactive tissue has been shown to occur during exercise (28).
Normally, with exercise, the increased blood
[H+] and
[Lac
] create an
inwardly directed [H+]
and [Lac
]
gradient, which facilitates uptake into inactive tissue. However, alkalosis decreases the
[H+] gradient and
therefore may reduce uptake compared with control conditions.
Summary and Conclusions
Induction of a metabolic alkalosis results in a complex series of
metabolic effects during exercise reflecting changes in the activity of
key regulatory enzymes and fuel utilization. The main findings of the
study demonstrate that alkalosis during 60%
O2 max leads to
increased glycogen utilization and pyruvate production as a result of
posttransformational allosteric activation of Phos mediated by
increases in ADPf,
AMPf, and free
Pi concentrations. Greater
PDHa transformation also occurs
with alkalosis at this moderate intensity as a result of the combined
inhibitory effects of a decrease in [acetyl-CoA], an
increase in the ADPf, pyruvate, and Ca2+ concentrations on PDHK,
and the stimulatory effects of an increase in the
[H+] on PDHP. The net
result is an enhanced pyruvate oxidation and therefore a lack of an
increase in lactate production. The increase in intramuscular
[Lac